← Back
Data updated: Mar 10, 2026
CHAMBERLIN PARENTERL
Pharmaceuticals
CHAMBERLIN PARENTERL is a pharmaceutical company with 1 FDA-approved products.
-
Since
1
Drugs
-
Trials
13
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2025-09-24
Labeling
HEPARIN SODIUM 2025-05-27
Labeling
HEPARIN SODIUM 2025-05-27
Labeling
HEPARIN SODIUM 2025-04-09
Labeling
HEPARIN SODIUM 2025-02-04
Labeling
HEPARIN SODIUM 2024-10-24
Labeling
HEPARIN SODIUM 2024-10-24
Labeling
HEPARIN SODIUM 2024-10-24
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...